Cena / výnosy spoločnosti Theratechnologies
Aká je hodnota metriky Cena / výnosy spoločnosti Theratechnologies?
Hodnota metriky Cena / výnosy spoločnosti Theratechnologies Inc. je 1.20
Aká je definícia metriky Cena / výnosy?
Cena / výnosy (Price to sales ratio) ukazateľ predstavuje cenu spoločnosti v porovnaní s výškou jej tržieb.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Cena / výnosy spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Theratechnologies
Čomu sa venuje spoločnosť Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Firmy s metrikou cena / výnosy podobnou spoločnosti Theratechnologies
- Hodnota metriky Cena / výnosy spoločnosti Vulcan Steel Ltd je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Clifford Modern Living je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Bhageria Industries je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Hind Rectifiers je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Top Spring International je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Changsha Broad Homes Industrial Co je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Theratechnologies je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Qinqin Foodstuffs (Cayman) je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Acusphere je 1.20
- Hodnota metriky Cena / výnosy spoločnosti TCPL Packaging je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Total Gabon je 1.20
- Hodnota metriky Cena / výnosy spoločnosti USD Partners LP je 1.20
- Hodnota metriky Cena / výnosy spoločnosti Wuhan Bester Telecom Co je 1.20